Huiyong Yin
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville TN 37232-6602, USA
Erik S. Musiek
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville TN 37232-6602, USA
Jason D. Morrow
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville TN 37232-6602, USA
ABSTRACT
Isoprostanes are prostaglandin-like compounds formed from the free radical-catalyzed peroxidation of arachidonic acid independent of the cyclooxygenase enzymes. The isoprostanes possess potent biological activity and likely mediate certain aspects of the detrimental effects of oxidant stress. The purpose of this study was to summarize the current knowledge regarding novel aspects related to the biochemistry of isoprostane formation and analytical methods by which these compounds are analyzed. A considerable portion of this review deals with the utility of measuring isoprostanes as markers of oxidant injury both in vitro and in vivo. A number of studies have shown that these compounds are extremely accurate indices of lipid peroxidation in animal models of oxidative stress and in certain human diseases. Thus the isoprostanes may have an important role in the pathophysiology of oxidant injury associated with a number of human disorders.
PDF References
How to cite this article
Huiyong Yin, Erik S. Musiek and Jason D. Morrow, 2006. Quantification of Isoprostanes as an Index of Oxidative Stress: A Update. Journal of Biological Sciences, 6: 469-479.
DOI: 10.3923/jbs.2006.469.479
URL: https://scialert.net/abstract/?doi=jbs.2006.469.479
DOI: 10.3923/jbs.2006.469.479
URL: https://scialert.net/abstract/?doi=jbs.2006.469.479
REFERENCES
- Aleynik, S.I., M.A. Leo, M.K. Aleynik, C.S. Lieber, 1998. Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcohol Clinc. Exp. Res., 22: 192-196.
Direct Link - Awad, J.A., J.D. Morrow, K.E. Hill, L.J. Roberts and R.F. Burk, 1994. Detection and localization of lipid peroxidation in selenium- and vitamin-E deficient rats using F2-isoprostanes. J. Nutr., 124: 810-816.
Direct Link - Basu, S., 2004. Isoprostanes: Novel bioactive products of lipid peroxidation. Free Rad. Res., 38: 105-122.
PubMedDirect Link - Bohnstedt, K.C., B. Karlberg, L.O. Wahlund, M.E. Jonhagen, H. Basun and S. Schmidt, 2003. Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometry. J. Chromatogr., 796: 11-19.
Direct Link - Boushey, C.J., S.A. Beresford, G.S. Omenn and A.G. Motulsky, 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. J. Am. Med. Assoc., 274: 1049-1057.
CrossRefDirect Link - Carpenter, C.T., P.V. Price and B.W. Christman, 1998. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest, 114: 1653-1659.
Direct Link - Davi, G., P. Alessandrini, A. Mezzetti, G. Minotti and T. Bucciarelli et al., 1997. In vivo formation of 8-epi-prostaglandin F2{α} is increased in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol., 17: 3230-3235.
PubMedDirect Link - Davies, S.S., V. Amarnath, I. Roberts and L. Jackson, 2004. Isoketals: Highly reactive [gamma]-ketoaldehydes formed from the H2-isoprostane pathway. Chem. Phys. Lipids, 128: 85-99.
PubMedDirect Link - Fam, S.S. and J.D. Morrow, 2003. The isoprostanes: Unique products of arachidonic acid oxidation-a review. Curr. Med. Chem., 10: 1723-1740.
Direct Link - Gao, L., W.E. Zackert, J.J. Hasford, M.E. Danekis and G.L. Milne et al., 2003. Formation of prostaglandins E2 and D2 via the isoprostane pathway: A mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase. J. Biol. Chem., 278: 28479-28489.
PubMedDirect Link - Gniwotta, C., J.D. Morrow, L.J. Roberts and H. II, Kuhn, 1997. Prostaglandin F2-like compounds, F2-Isoprostanes are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc. Biol., 17: 3236-3241.
PubMedDirect Link - Gopaul, N.K., J. Nourooz-Zadeh, A.I. Mallet and E.E. Anggard, 1994. Formation of F2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett., 348: 297-300.
Direct Link - Halliwell, B. and M. Grootveld, 1987. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett., 213: 9-14.
CrossRefPubMedDirect Link - Holt, S., B. Reeder, M. Wilson, S. Harvey, J.D. Morrow, L.J. Roberts II and K. Moore, 1999. Increased lipid peroxidation in patients with rhabdomyolysis. Lancet, 353: 1241-1241.
PubMedDirect Link - Kadiiska, M.B., B.C. Gladen, D.D. Baird, D. Germolec and L.B. Graham et al., 2005. Biomarkers of oxidative stress study II: Are oxidation products of lipids, proteins and DNA markers of CCl4 poisoning? Free Radic. Biol. Med., 38: 698-710.
CrossRefPubMedDirect Link - Kadiiska, M.B., B.C. Gladen, D.D. Baird, L.B. Graham and C.E. Parker et al., 2005. Biomarkers of oxidative stress study: III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Rad. Biol. Med., 38: 711-718.
Direct Link - Kannel, W.B., 1981. Update on the role of cigarette smoking in coronary artery disease. Am. Heart J., 101: 319-328.
PubMedDirect Link - Kenar, J.A., C.M. Havrilla, N.A. Porter, J.R. Guyton, S.A. Brown, K.R. Klemp and E. Selinger, 1996. Identification and quantification of the regioisomeric cholesteryl linoleate hydroperoxides in oxidized human low density lipoprotein and high density lipoprotein. Chem. Res. Toxicol., 9: 737-744.
Direct Link - Lawson, J.A., J. Rokach and G.A. FitzGerald, 1999. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo. J. Biol. Chem., 274: 24441-24444.
PubMedDirect Link - Liang, Y., P. Wei, R.W. Duke, P.W. Reaven, S.M. Harman, R.G. Cutler and C.B. Heward, 2003. Quantification of 8-iso-prostaglandin-F2 and 2,3-dinor-8-iso-prostaglandin-F2α in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol. Med., 34: 409-418.
CrossRefDirect Link - Li, H., J.A. Lawson, M. Reilly, M. Adiyaman, S.W. Hwang, J. Rokach and G.A. FitzGerald, 1999. Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F2-isoprostanes in human urine. PNAS., 96: 13381-13386.
Direct Link - Longmire, A.W., L.J. Roberts and J.D. Morrow, 1994. Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: Additional evidence for the existence of a unique isoprostane receptor. Prostaglandins, 48: 247-256.
PubMedDirect Link - Lynch, S.M., J.D. Morrow, L.J. Roberts and B. Frei, 1994. Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J. Clin. Invest., 93: 998-1004.
CrossRefDirect Link - Markesberry, W.R., 1997. Oxidative stress hypothesis in alzheimer's disease. Free Radic. Biol. Med., 23: 134-147.
PubMedDirect Link - Marin, J.G., S. Cornet, B. Spinnewyn, C. Demerle-Pallardy, M. Auguet and P.E. Chabrier, 2000. BN 80933 Inhibits F2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures. Neuroreport, 11: 1357-1360.
PubMedDirect Link - Milne, G.L., G. Zanoni, A. Porta, G. Vidari, E.S. Musiek, M.L. Freeman and J.D. Morrow, 2004. The cyclopentenone product of lipid peroxidation, 15-A2t-Isoprostane is efficiently metabolized by HepG2 cells via conjugation with glutathione. Chem. Res. Toxicol., 17: 17-25.
Direct Link - Milne, G.L., J.R. Seal, C.M. Havrilla, M. Wijtmans and N.A. Porter, 2005. Identification and analysis of products formed from phospholipids in the free radical oxidation of human low density lipoproteins. J. Lipid Res., 46: 307-319.
PubMedDirect Link - Montine, T.J., W.R. Markesberry, J.D. Morrow and L.J. Roberts, Jr., 1998. Cerebrospinal fluid F-2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol., 44: 410-413.
PubMedDirect Link - Montine, T.J., M.F. Beal, M.E. Cudkowicz, H. O'Donnell, R.A. Margolin et al., 1999. Increased CSF F2-isoprostane concentration in probable AD. Neurology, 52: 562-565.
PubMedDirect Link - Montine, T.J., M.F. Beal, D. Robertson, M.E. Cudkowicz and I. Biaggioni et al., 1999. Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology, 52: 1104-1105.
PubMedDirect Link - Montine, T.J., J.F. Quinn, D. Milatovic, L.C. Silbert and T. Dang et al., 2002. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Ann. Neurol., 52: 175-179.
Direct Link - Montine, K.S., J.F. Quinn, J. Zhang, J.P. Fessel, I. Roberts, L. Jackson, J.D. Morrow, T.J. Montine, 2004. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem. Phy. Lipids, 128: 117-124.
PubMedDirect Link - Morrow, J.D., E. Hill, R.F. Burk, T.M. Nammour, K.F. Badr, L.J. Roberts, Jr., 1990. A series of prostaglandin-F2-like compounds are produced in vivo in humans by a noncyclooxygenase. Free Radical Catalyzed Mechanism. Proc. Nat. Acad. Sci. USA., 87: 9383-9387.
PubMedDirect Link - Morrow, J.D., T.M. Harris and L.J. Jr. Roberts, 1990. Noncyclooxygenase oxidative formation of a series of novel prostaglandins-analytical ramfications for measurement of eicosanoids. Anal. Biochem., 184: 1-10.
CrossRefDirect Link - Morrow, J.D., J.A. Awad, H.J. Boss, I.A. Blair and L.J. Roberts, 1992. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Nat. Acad. Sci. USA., 89: 10721-10725.
PubMedDirect Link - Morrow, J.D., B. Frei, A.W. Longmire, J.M. Gaziano and S.M. Lynch et al., 1995. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers-smoking as a cause of oxidative damage. Engl. J. Med., 332: 1198-1203.
PubMedDirect Link - Morrow, J.D. and L.J. Roberts, 1997. The isoprostanes: Unique bioactive products of lipid peroxidation. Prog. Lipid Res., 36: 1-21.
PubMedDirect Link - Morrow, J.D., Y. Chen, C.J. Brame, J. Yang and S.C. Sanchez et al., 1999. The Isoprostanes: Unique prostanglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab. Rev., 31: 117-139.
PubMedDirect Link - Morrow, J.D., 2005. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterisocler. Thromb. Vas. Biol., 25: 279-286.
Direct Link - Morales, C.R., E.S. Terry, W.E. Zackert, T.J. Montine and J.D. Morrow, 2001. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F2t-Isoprostane (8-iso-PGF2[α]) by a stable isotope dilution mass spectrometric assay. Clin. Chim. Acta, 314: 93-99.
CrossRefDirect Link - Musiek, E.S., J.K. Cha, H. Yin, W.E. Zackert and E.S. Terry et al., 2004. Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay. J. Chromatogr., 799: 95-102.
Direct Link - Natarajan, R., L. Lanting, N. Gonzales and J. Nadler, 1996. Formation of an F2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors. Am. J. Physiol. Heart Circ. Physiol., 271: H159-H165.
Direct Link - O'Connor, D.E., E.D. Mihelich and M.C. Coleman, 1981. Isolation and characterization of bicycloendoperoxides derived from methyl linolenate. J. Am. Chem. Soc., 103: 223-224.
CrossRefDirect Link - O'Connor, D.E., E.D. Mihelich and M.C. Coleman, 1984. Stereochemical course of the autooxidative cyclization of lipid hydroperoxides to prostaglandin-like bicyclic endoperoxides. J. Am. Chem. Soc., 106: 3577-3584.
CrossRefDirect Link - Patel, M., L.P. Liang and L.J. Roberts, 2001. Enhanced hippocampal F2-isoprostane formation following kainate-induced seizures. J. Neurochem., 79: 1065-1069.
Direct Link - Porter, N.A., 1986. Mechanisms for the autoxidation of polyunsaturated lipids. Acc. Chem. Res., 19: 262-268.
CrossRefDirect Link - Montine, T.J. and J.D. Morrow, 2005. Fatty acid oxidation in the pathogenesis of alzheimer's disease. Am. J. Pathol., 166: 1283-1289.
Direct Link - Porter, N.A., S.E. Caldwell and K.A. Mills, 1995. Mechanisms of free radical oxidation of unsaturated lipids. Lipids, 30: 277-290.
CrossRefDirect Link - Pratico, D. and G.A. FitzGerald, 1996. Generation of 8-Epiprostaglandin F2a by human monocytes. J. Biol. Chem., 271: 8919-8924.
Direct Link - Pratico, D., L. Iuliano, A. Mauriello, L. Spagnoli and J.A. Lawson et al., 1997. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J. Clin. Invest., 100: 2028-2034.
CrossRefDirect Link - Pratico, D., R.K. Tangirala, D.J. Rader, J. Rokach and G.A. Fitz-Gerald, 1998. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat. Med., 4: 1189-1192.
PubMedDirect Link - Pratico, D., C.M. Clark, V.M.Y. Lee, J.Q. Trojanowski, J. Rokach and G.A. FitzGerald, 2000. Increased 8,12-iso-iPF2-VI in Alzheimer's disease: Correlation of a noninvasive index of lipid peroxidation with disease severity. Ann. Neurol., 48: 809-812.
Direct Link - Pratico, D., K. Uryu, S. Leight, J.Q. Trojanoswki and V.M.Y. Lee, 2001. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of alzheimer amyloidosis. J. Neurosci., 21: 4183-4187.
Direct Link - Pratico, D., C.M. Clark, F. Liun, V.Y.M. Lee and J.Q. Trojanowski, 2002. Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of alzheimer disease. Arch Neurol., 59: 972-976.
PubMedDirect Link - Quan, L.G. and J.K. Cha, 2004. Recent advances in the stereoselective synthesis of isoprostanes and neuroprostanes. Chem. Phys. Lipids, 128: 3-14.
Direct Link - Reich, E.E., W.R. Markesbery, L.J.I. Roberts, L.L. Swift, J.D. Morrow and T.J. Montine, 2001. Brain regional quantification of f-ring and d-/e-ring isoprostanes and neuroprostanes in Alzheimer's Disease. Am. J. Pathol., 158: 293-297.
Direct Link - Reilly, M., N. Delanty, J.A. Lawson, G.A. FitzGerald, 1996. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation, 94: 19-25.
Direct Link - Roberts, L.J., K.P. Moore, W.E. Zackert, J.A. Oates and J.D. Morrow, 1996. Identification of the major urinary metabolite of the F2-isoprostane 8-Iso-prostaglandin F2α in humans. J. Biol. Chem., 271: 20617-20620.
Direct Link - Roberts, Jr. L.J., T.J. Montine, W.R. Markesbery, A.R. Tapper and P. Hardy et al., 1998. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem., 273: 13605-13612.
Direct Link - Roberts, I., L. Jackson and J.F. Reckelhoff, 2001. Measurement of F2-isoprostanes unveils profound oxidative stress in aged rats. Biochem. Biophys. Res. Comm., 287: 254-256.
CrossRefDirect Link - Rokach, J., S.P. Khanapure, S.W. Hwang, M. Adiyama, J.A. Lawson and G.A. FitzGerald, 1997. The isoprostanes: A perspective. Prostaglandins, 54: 823-851.
Direct Link - Stein, C.M., S.B. Tanner, J.A. Award, L.J. Roberts and J.D. Morrow, 1996. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arth. Rheum., 39: 1146-1150.
Direct Link - Steinberg, D., S. Parhasarathy, T.E. Carew, J.C. Khoo and J.L. Witztum, 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med., 320: 915-924.
PubMedDirect Link - Steinberg, D., 2004. Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: Part I. J. Lipid Res., 45: 1583-1593.
Direct Link - Steinberg, D., 2005. Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: Part II: The early evidence linking hypercholesterolemia to coronary disease in humans. J. Lipid Res., 46: 179-190.
CrossRefDirect Link - Tsan, L., A. Stern, L.J. Roberts and J.D. Morrow, 1999. The isoprostanes: Novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. J. Biomed. Sci., 6: 226-235.
CrossRefDirect Link - Voutilainen, S., J.D. Morrow, L.J. Roberts 2nd, G. Alfthan, H. Alho, K. Nyyssonen and J.T. Salonen, 1999. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb. Vasc. Biol., 19: 1263-1266.
Direct Link - Yin, H., C.M. Havrilla, J.D. Morrow and N.A. Porter, 2002. Formation of isoprostane bicyclic endoperoxides from the autoxidation of cholesteryl arachidonate. J. Am. Chem. Soc., 124: 7745-7754.
CrossRefDirect Link - Yin, H. and N.A. Porter, 2003. Specificity of the ferrous oxidation of xylenol orange assay: Analysis of autoxidation products of cholesteryl arachidonate. Anal. Biochem., 313: 319-326.
Direct Link - Yin, H. and N.A. Porter, 2005. New insights regarding the autoxidation of polyunsaturated fatty acids. Antioxidants Redox Signal., 7: 170-184.
Direct Link - Yin, H., C.M. Havrilla, L. Gao, J.D. Morrow and N.A. Porter, 2003. Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid: Dioxetane intermediate or beta-fragmentation of peroxyl radicals?. J. Biol. Chem., 278: 16720-16725.
Direct Link